D
iabetic retinopathy is the most common complication of diabetes and cause of legal blindness in aging Canadians. It is estimated two million Canadians (i.e. almost all people diagnosed with diabetes) have some form of diabetic retinopathy. As optometrists, you play a vital role in the care of your patients who have diabetes or pre-diabetes to screen, diagnose and prevent the onset and/ or progression of retinopathy. Type 1 and type 2 diabetes both carry risks for the development of proliferative retinopathy; with hyperglycemia being the single most important risk factor. The prevalence is 23% for people with type 1 diabetes, 14% for people with type 2 diabetes on insulin therapy, and 3% in those receiving oral anti-diabetes medications. The Canadian Diabetes Association actively supports clinical research to establish scientific evidence to address diabetic retinopathy. The following information represents the results of that research. 
Recommendations
In individuals ≥ 15 years of age with type 1 diabetes, screening and evaluation for retinopathy by an expert professional should be performed annually starting at five years after the onset of diabetes. In individuals with type 2 diabetes, screening and evaluation for diabetic retinopathy by an expert professional should be performed at the time of diagnosis of diabetes. The interval for follow-up assessments should be tailored to the severity of the retinopathy. In those with no or minimal retinopathy, the recommended interval is one to two years.
Screening for diabetic retinopathy should be performed by experienced professionals, either in person or through interpretation of retinal photographs taken through dilated pupils. To prevent onset and delay the progression of diabetic retinopathy, people with diabetes should be treated to achieve optimal control of blood glucose and BP. People with abnormal lipids should be considered at high risk for retinopathy.
Patients with sight-threatening diabetic retinopathy should be assessed by a general ophthamologist or retinal specialist. Consider laser therapy and/or vitrectomy and/or pharmacologic intervention.
Refer visually disabled people to low-vision evaluation and rehabiliatation.
Optometrists, the first line of eye care clinicians, can make a difference for people with diabetes and their eye care. We hope this information and the full chapter on retinopathy in the 2008 Clinical Practice Guidelines (found at diabetes.ca) will help you broaden delivery of care to your patients with diabetes. 
Recommandations
Chez les personnes de 15 ans et plus atteintes de diabète de type 1, un expert doit procéder au dépistage et à l'évaluation de la ré-tinopathie annuellement à compter de cinq ans après l'apparition du diabète. Chez les personnes atteintes de diabète de type 2, un expert doit procéder au dépistage et à l'évaluation de la rétinopathie diabétique au moment du diagnostic de diabète. L'intervalle entre les évaluations subséquentes doit être déterminé en fonction de la gravité de la rétinopathie. Chez les personnes qui ne présentent pas de rétinopathie ou qui présentent une rétinopathie minime, l'intervalle recommandé est de un à deux ans.
Le dépistage de la rétinopathie diabétique doit être effectué par des professionnels expérimen-tés soit en personne, soit par l'évaluation de photographies rétiniennes prises après dilatation des pupilles. Urgent help is needed to give sight to 300,000 people.
Patients waiting for eye exams and glasses at a temporary eye clinic in Sri Lanka.
The Problem.
670 million people do not have access to the eye exams and glasses they need. Without glasses, children may be unable to learn at school and parents unable to provide for their families.
The Solution.
Training local eye care professionals and establishing community based vision centres and optical workshops are the only way to solve this global problem.
• Establish 10 Vision Centres 
